Learn how parallel medicinal chemistry (PMC) and high-throughput experimentation (HTE) can provide a more focused approach to target molecules, resulting...
Continue Reading
As part of our autoimmune and inflammatory disease platform, we provide an extensive panel of monosodium urate (MSU) induced gout...
Continue Reading Comprehensive portfolio of drug resistant models representing clinically relevant mechanisms of resistance: 10+ cancer types 25+ key targets 30+ leading...
Continue Reading Offering a wide range of targeted oncology services and translational models. Our comprehensive platform includes: in vitro biochemical, biophysical, and...
Continue Reading Providing a comprehensive panel of large animal disease models across multiple species, including NHP, mini-pig, dog, and rabbit. Models for...
Continue Reading Comprehensive platform of over 40 disease models (including NHPs and other large animals), covering a wide range of indications and...
Continue Reading We offer an extensive panel of cutting-edge immune profiling and biomarker discovery services to support: Target discovery and validation Drug...
Continue Reading Comprehensive cell line screening assays integrated with downstream pharmacological services Cell panel of 600+ human cancer cell lines for single...
Continue Reading Multidisciplinary testing platforms that enable support to detect, develop, and validate biomarkers of cancer. End-to-end services in pathology, flow cytometry,...
Continue Reading
